New study sets baseline for clotting test in pregnancy to spot hidden risks
NCT ID NCT06133621
First seen Jan 06, 2026 · Last updated May 25, 2026 · Updated 30 times
Summary
This study aims to determine normal reference values for a blood clotting test called dRVVT in healthy pregnant women. Pregnancy naturally increases the risk of blood clots, and abnormal test results can signal antiphospholipid syndrome, a condition that raises the chance of serious pregnancy complications. By testing 100 women with normal pregnancies, researchers hope to improve diagnosis and management of clotting disorders during pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NORMAL PREGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dr Céline BAZIN
Lyon, France
Conditions
Explore the condition pages connected to this study.